BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $858 | -53.6% | 885 | 0.0% | 0.02% | -59.3% |
Q2 2023 | $1,850 | -25.6% | 885 | 0.0% | 0.05% | -39.3% |
Q1 2023 | $2,487 | +24.9% | 885 | 0.0% | 0.09% | +67.9% |
Q4 2022 | $1,991 | -0.4% | 885 | 0.0% | 0.05% | +71.0% |
Q3 2022 | $2,000 | -33.3% | 885 | 0.0% | 0.03% | -11.4% |
Q2 2022 | $3,000 | -62.5% | 885 | 0.0% | 0.04% | -32.7% |
Q1 2022 | $8,000 | 0.0% | 885 | 0.0% | 0.05% | -84.8% |
Q4 2021 | $8,000 | -50.0% | 885 | 0.0% | 0.34% | -32.9% |
Q3 2021 | $16,000 | -38.5% | 885 | 0.0% | 0.51% | +39.9% |
Q2 2021 | $26,000 | +8.3% | 885 | 0.0% | 0.36% | +785.4% |
Q1 2021 | $24,000 | +20.0% | 885 | 0.0% | 0.04% | +13.9% |
Q4 2020 | $20,000 | – | 885 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,812,569 | $48,957,000 | 3.80% |
Casdin Capital, LLC | 1,730,786 | $46,749,000 | 2.77% |
Orbimed Advisors | 4,746,071 | $128,191,000 | 1.80% |
HSG Holding Ltd | 212,121 | $5,729,000 | 1.02% |
Aspex Management (HK) Ltd | 292,418 | $7,898,000 | 0.97% |
Pinz Capital Management, LP | 30,000 | $810,000 | 0.37% |
Cormorant Asset Management, LP | 250,000 | $6,753,000 | 0.26% |
Hudson Bay Capital Management LP | 537,311 | $14,512,000 | 0.25% |
Rock Springs Capital Management LP | 200,000 | $5,402,000 | 0.15% |
Monashee Investment Management LLC | 30,000 | $810,000 | 0.12% |